Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...
المؤلفون الرئيسيون: | Sear, CE, Pieper, P, Amaral, M, Romanelli, MM, Costa-Silva, TA, Haugland, MM, Tate, JA, Lago, JHG, Tempone, AG, Anderson, EA |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
American Chemical Society
2020
|
مواد مشابهة
-
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
حسب: Amaral, M, وآخرون
منشور في: (2023) -
Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
حسب: Ferreira, D, وآخرون
منشور في: (2019) -
Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
حسب: de Sousa, FS, وآخرون
منشور في: (2020) -
Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
حسب: Sear, C
منشور في: (2020) -
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against <i>Trypanosoma cruzi</i>
حسب: Mariana C. Pagotti, وآخرون
منشور في: (2023-02-01)